Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test

Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test

August 24, 2026Posted inMedical Technology

Roche and Eli Lilly have won FDA clearance for their latest Alzheimer’s disease diagnostic.

Post navigation

Previous Post
triglyceride-glucose-index-linked-to-elevated-blood-pressure-in-us.-teens Triglyceride-Glucose Index Linked to Elevated Blood Pressure in U.S. Teens
Next Post
How Chromosomes Find Their Matching Partners how-chromosomes-find-their-matching-partners

Recent Posts

  • Metabolomic Profiling Identifies Key Lipid and Redox Alterations in Methylmalonic Acidemia
  • First Vaginal Fibroepithelial Polyp Diagnosed and Surgically Removed in Ring-Tailed Lemur
  • Vagus Nerve Stimulation Restores Hippocampal Proteins in Mouse Cognitive Impairment Model
  • Biologists Discover Two New Freshwater Snail Species in Mountainous Southwestern China
  • Reef Fishes Occupy Unique Spatial Niches Despite Shared Habitat Preferences

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top